End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.61 CNY | +2.96% | +9.43% | +0.84% |
Apr. 26 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
Apr. 17 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Neutral |
Resistance | 47.28 | 49.28 | 49.13 |
Spread/Res. | -3.53% | -7.45% | -7.16% |
Spread/Supp. | +9.43% | +26.87% | +26.87% |
Support | 41.68 | 35.95 | 35.95 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 600276 Stock
- Charts Jiangsu Hengrui Medicine Co., Ltd.